Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation

Breast Cancer Research and Treatment

Volumn 157, Issue 3, 2016, Pages 461-474

  Szalayova, Gabriela ^a,b,c   Ogrodnik, Aleksandra ^a,b,c   Spencer, Brianna ^a,c   Wade, Jacqueline ^a,c   Bunn, Janice ^d   Ambaye, Abiy ^a   James, Ted ^a   Rincon, Mercedes ^c  

^a UNIVERSITY OF VERMONT   (United States)

^b DANBURY HOSPITAL   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Biopsy; Breast cancer; Eosinophils; Inflammation; Metastasis

Indexed keywords

ADULT; AGED; ARTICLE; BIOACCUMULATION; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER SURGERY; CANCER TISSUE; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CORE NEEDLE BIOPSY; EOSINOPHIL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; METASTASIS; NEEDLE BIOPSY; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR BIOPSY; TUMOR MICROENVIRONMENT; BREAST TUMOR; DISEASE EXACERBATION; FEMALE; IMMUNOLOGY; INJURY; LARGE CORE NEEDLE BIOPSY; MACROPHAGE; MIDDLE AGED; PATHOLOGY; TUMOR CELL CULTURE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOPSY, LARGE-CORE NEEDLE; BREAST NEOPLASMS; CELL PROLIFERATION; DISEASE PROGRESSION; EOSINOPHILS; FEMALE; HUMANS; MACROPHAGES; MIDDLE AGED; NEOPLASM METASTASIS; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT; WOUNDS AND INJURIES;

EID: 84973168528     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-016-3839-3     Document Type: Article

References (36)

1. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, et al (2015) SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. Bethesda. http://www.seercancergov/csr/1975_2012/ based on November 2014 SEER data submission, posted to the SEER web site, April 2015
2. Shiao SL, Ganesan AP, Rugo HS, Coussens LM (2011) Immune microenvironments in solid tumors: new targets for therapy. Genes Dev 25:2559–2572
3. Shalapour S, Karin M (2015) Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Invest 125:3347–3355
4. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–899
5. Bhatelia K, Singh K, Singh R (2014) TLRs: linking inflammation and breast cancer. Cell Signal 26:2350–2357
6. Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E et al (2010) Cancer and inflammation: promise for biologic therapy. J Immunother 33:335–351
7. Grivennikov SI, Karin M (2011) Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 70(Suppl 1):i104–i108
8. Multhoff G, Molls M, Radons J (2011) Chronic inflammation in cancer development. Front Immunol 2:98
9. Coussens LM, Pollard JW (2011) Leukocytes in mammary development and cancer. Cold Spring Harb Perspect Biol 3:a003285
10. Szalayova G, James TA, Rincon M (2015) A framework for the role of acute inflammation in tumor progression. Breast Cancer Res Treat 151:235–238
11. Arnold KM, Opdenaker LM, Flynn D, Sims-Mourtada J (2015) Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer. Cancer Growth Metastas 8:1–13
12. Ceelen W, Pattyn P, Mareel M (2014) Surgery, wound healing, and metastasis: recent insights and clinical implications. Crit Rev Oncol Hematol 89:16–26
13. Fitzal F, Sporn EP, Draxler W, Mittlbock M, Taucher S, Rudas M, Riedl O, Helbich TH, Jakesz R, Gnant M (2006) Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients. Breast Cancer Res Treat 97:9–15
14. Chen AM, Haffty BG, Lee CH (2002) Local recurrence of breast cancer after breast conservation therapy in patients examined by means of stereotactic core-needle biopsy. Radiology 225:707–712
15. King TA, Hayes DH, Cederbom GJ, Champaign JL, Smetherman DH, Farr GH, Bolton JS, Fuhrman GM (2001) Biopsy technique has no impact on local recurrence after breast-conserving therapy. Breast J 7:19–24
16. Hoorntje LE, Schipper ME, Kaya A, Verkooijen HM, Klinkenbijl JG, Borel Rinkes IH (2004) Tumour cell displacement after 14G breast biopsy. Eur J Surg Oncol 30:520–525
17. Thurfjell MG, Jansson T, Nordgren H, Bergh J, Lindgren A, Thurfjell E (2000) Local breast cancer recurrence caused by mammographically guided punctures. Acta Radiol 41:435–440
18. Chao C, Torosian MH, Boraas MC, Sigurdson ER, Hoffman JP, Eisenberg BL, Fowble B (2001) Local recurrence of breast cancer in the stereotactic core needle biopsy site: case reports and review of the literature. Breast J 7:124–127
19. Hobson J, Gummadidala P, Silverstrim B, Grier D, Bunn J, James T, Rincon M (2013) Acute inflammation induced by the biopsy of mouse mammary tumors promotes the development of metastasis. Breast Cancer Res Treat 139:391–401
20. Pollard JW (2008) Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol 84:623–630
21. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625–4629
22. Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605–612
23. Ham M, Moon A (2013) Inflammatory and microenvironmental factors involved in breast cancer progression. Arch Pharmacal Res 36:1419–1431
24. Butowski N, Colman H, De Groot JF, Omuro AM, Nayak L, Wen PY, Cloughesy TF, Marimuthu A, Haidar S, Perry A et al (2015) Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neuro-oncology 18(4):557–564
25. von Tresckow B, Morschhauser F, Ribrag V, Topp MS, Chien C, Seetharam S, Aquino R, Kotoulek S, de Boer CJ, Engert A (2015) An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R inhibitor, in patients with relapsed or refractory hodgkin lymphoma. Clin Cancer Res 21:1843–1850
26. Zhang YJ, Wei L, Li J, Zheng YQ, Li XR (2013) Status quo and development trend of breast biopsy technology. Gland Surg 2:15–24
27. Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, Widmann WD (2012) Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 19:217–224
28. Nozawa H, Chiu C, Hanahan D (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103:12493–12498
29. Bald T, Quast T, Landsberg J, Rogava M, Glodde N, Lopez-Ramos D, Kohlmeyer J, Riesenberg S, van den Boorn-Konijnenberg D, Homig-Holzel C et al (2014) Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 507:109–113
30. Ravin KA, Loy M (2016) The eosinophil in infection. Clin Rev Allerg Immunol 50(2):214–227
31. Stone KD, Prussin C, Metcalfe DD (2010) IgE, mast cells, basophils, and eosinophils. J Allerg Clin Immunol 125:S73–S80
32. Spencer LA, Bonjour K, Melo RC, Weller PF (2014) Eosinophil secretion of granule-derived cytokines. Front Immunol 5:496
33. Amini RM, Aaltonen K, Nevanlinna H, Carvalho R, Salonen L, Heikkila P, Blomqvist C (2007) Mast cells and eosinophils in invasive breast carcinoma. BMC Cancer 7:165
34. Dethlefsen C, Hojfeldt G, Hojman P (2013) The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res Treat 138:657–664
35. Tawara K, Oxford JT, Jorcyk CL (2011) Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies. Cancer Manag Res 3:177–189
36. Conze D, Weiss L, Regen PS, Bhushan A, Weaver D, Johnson P, Rincon M (2001) Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells. Cancer Res 61:8851–8858